# Morphine for Treatment of Dyspnea in Patients With COPD

> **NCT02429050** · PHASE4 · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 124 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** sustained release morphine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02429050
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-16
- **Primary completion:** 2019-03-06
- **Final completion:** 2019-07-01
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2019-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02429050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02429050, "Morphine for Treatment of Dyspnea in Patients With COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02429050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*